Implementing and Scaling Up HCV Treatment Services for People Who Inject Drugs and Other High Risk Groups in Ukraine: An Evaluation of Programmatic and Treatment Outcomes

BACKGROUND: HCV prevalence estimates among people who inject drugs (PWID) in Ukraine is high (60%-90%), yet barriers to HCV treatment and care remain substantial including limited access to direct acting antiviral (DAA) medications. A feasibility scale-up project implemented HCV treatment in communi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Drug Policy
Autores principales: Mazhnaya, Alyona, Meteliuk, Anna, Barnard, Tetiana, Zelenev, Alexei, Filippovych, Sergii, Altice, Frederick L.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5918282/
https://ncbi.nlm.nih.gov/pubmed/28811159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugpo.2017.07.023
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares